Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2
Genes · 2023
DOI: 10.3390/genes14101879 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, 2023. Verfasst von Mzwanele Ngubo und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Sprott Centre for Stem Cell Research, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada. Hauptthemen laut MEDLINE: Drosophila Proteins, Histones. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
The Polycomb repressive complex 2 (PRC2) is a conserved chromatin-remodelling complex that catalyses the trimethylation of histone H3 lysine 27 (H3K27me3), a mark associated with gene silencing. PRC2 regulates chromatin structure and gene expression during organismal and tissue development and tissue homeostasis in the adult. PRC2 core subunits are associated with various accessory proteins that modulate its function and recruitment to target genes. The multimeric composition of accessory proteins results in two distinct variant complexes of PRC2, PRC2.1 and PRC2.2. Metal response element-binding transcription factor 2 (MTF2) is one of the Polycomb-like proteins (PCLs) that forms the PRC2.1 complex. MTF2 is highly conserved, and as an accessory subunit of PRC2, it has important roles in embryonic stem cell self-renewal and differentiation, development, and cancer progression. Here, we review the impact of MTF2 in PRC2 complex assembly, catalytic activity, and spatiotemporal function. The emerging paradoxical evidence suggesting that MTF2 has divergent roles as either a tumour suppressor or an oncogene in different tissues merits further investigations. Altogether, our review illuminates the context-dependent roles of MTF2 in Polycomb group (PcG) protein-mediated epigenetic regulation. Its impact on disease paves the way for a deeper understanding of epigenetic regulation and novel therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Sprott Centre for Stem Cell Research, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.
- Ottawa Institute of Systems Biology, Ottawa, ON K1H 8M5, Canada.
- Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1N 6N5, Canada.
- Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
ORCID-Profile: Mzwanele Ngubo, William L Stanford
Förderung
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Ngubo, M., Moradi, F., Ito, C. Y., & Stanford, W. L. (2023). Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2. Genes. https://doi.org/10.3390/genes14101879
Vancouver
Ngubo M, Moradi F, Ito CY, Stanford WL. Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2. Genes. 2023. doi:10.3390/genes14101879
BibTeX
@article{Ngubo2023,
author = {Ngubo, Mzwanele and Moradi, Fereshteh and Ito, Caryn Y and Stanford, William L},
title = {Tissue-Specific Tumour Suppressor and Oncogenic Activities of the Polycomb-like Protein MTF2},
journal = {Genes},
year = {2023},
doi = {10.3390/genes14101879}
}
EUVIMED